Postdoc: Molecular Pharmacology & GPCR Research

Initial Therapeutics, Inc.; Indianapolis (IN); On-site; USD 58,000 - 123,200; Full time

Benefits offered by this job

Comprehensive benefit program

401(k) and pension

Company bonuses

Flextime and well-being benefits

Job summary

Initial Therapeutics, Inc. is seeking a talented Post-Doctoral Scientist in Molecular Pharmacology to join their dynamic research team in Indianapolis, Indiana. This role involves conducting cutting-edge studies on GPCR ligands and collaborating with top scientists in the field.

The ideal candidate will have a PhD in a relevant scientific discipline, strong research skills, and a commitment to publishing research. Full-time employees will also enjoy a comprehensive benefits package including medical, dental, and vision care.

Qualifications

• PhD in pharmacology or related life science discipline required by October 2026.
• Must be authorized to work in the United States on a full-time basis.
• Strong or developing publication record with excellent communication skills.

Responsibilities

• Conduct molecular pharmacology studies on GPCR ligands.
• Work with molecular pharmacologists and present findings.
• Publish research in peer-reviewed journals.

Skills

Research and communication skills

Data analysis

Graphing

Scientific reporting

Ligand binding techniques

Cell culture techniques

Pharmacological modelling

Education

PhD in pharmacology, biochemistry

Tools

GraphPad Prism

Python

Excel

PyMOL

MOE

Job description

Initial Therapeutics, Inc. is seeking a talented Post-Doctoral Scientist in Molecular Pharmacology to join their dynamic research team in Indianapolis, Indiana. This role involves conducting cutting-edge studies on GPCR ligands and collaborating with top scientists in the field.

The ideal candidate will have a PhD in a relevant scientific discipline, strong research skills, and a commitment to publishing research. Full-time employees will also enjoy a comprehensive benefits package including medical, dental, and vision care.